Literature DB >> 14450866

Intra-articular dissociation of the rheumatoid factor.

I A JAFFE.   

Abstract

Entities:  

Keywords:  ANEMIA, HEMOLYTIC/immunology; RHEUMATISM; SERUM GLOBULIN; VALINE/related compounds

Mesh：

Substances：

Year:  1962        PMID： 14450866

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  16 in total

1.  [ON THE BEHAVIOR OF THE RHEUMATOID FACTOR UNDER THE INFLUENCE OF PENICILLAMINE AND PENICILLIN IN PRIMARY CHRONIC POLYARTHRITIS (RHEUMATOID ARTHRITIS)].

Authors:  E PROHASKA; W SCHWAEGERL; H JESSERER
Journal:  Klin Wochenschr       Date:  1965-02-01

2.  Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor.

Authors:  I A JAFFE
Journal:  Ann Rheum Dis       Date:  1963-03       Impact factor: 19.103

3.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors:  T Matsubara; R Saura; K Hirohata; M Ziff
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  D-penicillamine in rheumatoid arthritis.

Authors:  P Junker
Journal:  Indian J Pediatr       Date:  1986 Sep-Oct       Impact factor: 1.967

5.  D-penicillamine: mitogenic effect on mouse, rat and human spleen lymphocytes.

Authors:  M H Claësson; G S Hansen; V Tjell
Journal:  Med Microbiol Immunol       Date:  1979-08       Impact factor: 3.402

Review 6.  Current status of disease-modifying drugs in progressive rheumatoid arthritis.

Authors:  J D O'Duffy; H S Luthra
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

7.  Effects of soluble immune complexes on Fc receptor- and C3b receptor-mediated phagocytosis by macrophages.

Authors:  F M Griffin
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

Review 8.  Clinical pharmacokinetics of D-penicillamine.

Authors:  P Netter; B Bannwarth; P Péré; A Nicolas
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

9.  The effect of D-penicillamine on polymorphonuclear leukocyte function.

Authors:  H Chwalinska-Sadowska; J Baum
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.

Authors:  A J Dixon; J Davies; T L Dormandy; E B Hamilton; P J Holt; R M Mason; M Thompson; J C Weber; D W Zutshi
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.